Cargando…

Identification of Natural Compounds against Neurodegenerative Diseases Using In Silico Techniques

The aim of this study was to identify new potentially active compounds for three protein targets, tropomyosin receptor kinase A (TrkA), N-methyl-d-aspartate (NMDA) receptor, and leucine-rich repeat kinase 2 (LRRK2), that are related to various neurodegenerative diseases such as Alzheimer’s, Parkinso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivanova, Larisa, Karelson, Mati, Dobchev, Dimitar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222649/ https://www.ncbi.nlm.nih.gov/pubmed/30044400 http://dx.doi.org/10.3390/molecules23081847

Ejemplares similares

Multitarget Approach to Drug Candidates against Alzheimer’s Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets
por: Ivanova, Larisa, et al.
Publicado: (2020)

The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy
por: Ivanova, Larisa, et al.
Publicado: (2022)

Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
por: Ivanova, Larisa, et al.
Publicado: (2018)

1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors
por: Ivanova, Larisa, et al.
Publicado: (2021)

Molecular Dynamics Simulations of the Interactions between Glial Cell Line-Derived Neurotrophic Factor Family Receptor GFRα1 and Small-Molecule Ligands
por: Ivanova, Larisa, et al.
Publicado: (2018)

Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
por: Mohd Sairazi, Nur Shafika, et al.
Publicado: (2020)

Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
por: Marino, Attilio, et al.
Publicado: (2022)

In Silico Identification of Multi-Target Ligands as Promising Hit Compounds for Neurodegenerative Diseases Drug Development
por: Alov, Petko, et al.
Publicado: (2022)

In Silico Studies in Drug Research Against Neurodegenerative Diseases
por: Makhouri, Farahnaz Rezaei, et al.
Publicado: (2018)

EDITORIAL In Silico Studies in Drug Research Against Neurodegenerative Diseases
por: Scotti, Luciana, et al.
Publicado: (2018)

Possible protective action of neurotrophic factors and natural compounds against common neurodegenerative diseases
por: Numakawa, Tadahiro
Publicado: (2014)

Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases
por: Leuci, Rosalba, et al.
Publicado: (2020)

Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation
por: Ivanova, Larisa, et al.
Publicado: (2021)

Antimicrobial activity of methanolic extracts of Vernonia cinerea against Xanthomonas oryzae and identification of their compounds using in silico techniques
por: Joshi, Tushar, et al.
Publicado: (2021)

Recent Updates in the Treatment of Neurodegenerative Disorders Using Natural Compounds
por: Rasool, Mahmood, et al.
Publicado: (2014)

Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer’s Disease: An In Silico Molecular Docking Simulation and ADMET Study
por: Jamal, Qazi Mohammad Sajid, et al.
Publicado: (2023)

Screening of Multitarget-Directed Natural Compounds as Drug Candidates for Alzheimer’s Disease Using In Silico Techniques: Their Extraction and In Vitro Validation
por: Srivastava, Sukriti, et al.
Publicado: (2023)

In silico identification of natural compounds against SARS-CoV-2 main protease from Chinese herbal medicines
por: Kuang, Yi, et al.
Publicado: (2023)

The Drosophila Model: Exploring Novel Therapeutic Compounds against Neurodegenerative Diseases
por: Cha, Sun Joo, et al.
Publicado: (2019)

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
por: Andrade, Stéphanie, et al.
Publicado: (2023)

Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
por: Selberg, Simona, et al.
Publicado: (2021)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence
por: Kolodkin, Alexey, et al.
Publicado: (2012)

Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

A new insight into identification of in silico analysis of natural compounds targeting GPR120
por: Chinthakunta, Nagaraju, et al.
Publicado: (2018)

The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo
por: Lin, Shian-Ren, et al.
Publicado: (2019)

Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
por: Amato, Antonella, et al.
Publicado: (2019)

In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
por: Sankar, Muthumanickam, et al.
Publicado: (2021)

Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
por: Ali, Shahid, et al.
Publicado: (2022)

Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico
por: Abduljalil, Jameel M., et al.
Publicado: (2023)

Structure based molecular inhibition of Caspase-8 for treatment of multi-neurodegenerative diseases using known natural compounds
por: Ahmad, Khurshid, et al.
Publicado: (2014)

Capturing antibacterial natural products with in silico techniques
por: Masalha, Mahmud, et al.
Publicado: (2018)

In Silico Screening of Synthetic and Natural Compounds to Inhibit the Binding Capacity of Heavy Metal Compounds against EGFR Protein of Lung Cancer
por: Ayaz, Zainab, et al.
Publicado: (2022)

In-Silico Identification of Natural Compounds from Traditional Medicine as Potential Drug Leads against SARS-CoV-2 Through Virtual Screening
por: Mithilesh, Sai, et al.
Publicado: (2022)

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro
por: Hassam, Muhammad, et al.
Publicado: (2022)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

In silico analysis and molecular docking studies of natural compounds of Withania somnifera against bovine NLRP9
por: Ali, Aarif, et al.
Publicado: (2023)

Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer’s Disease
por: Castaneda, Andrea, et al.
Publicado: (2021)

Natural Bioactive Products with Antioxidant Properties Useful in Neurodegenerative Diseases
por: Mendonça-Junior, Francisco J. B., et al.
Publicado: (2019)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
por: Wakamatsu, Keiji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ugrfb7v4jm519kpg9s3suj8qjm